Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institute of Cancer Research, United Kingdom
Swiss Cancer Institute
University of Washington
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
St. Olavs Hospital
Jonsson Comprehensive Cancer Center
Maastricht University Medical Center
Duke University
Case Comprehensive Cancer Center
University Health Network, Toronto
Fox Chase Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
Dana-Farber Cancer Institute
Shanghai Junshi Bioscience Co., Ltd.
Peking University First Hospital
Karolinska Institutet
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
OHSU Knight Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Icahn School of Medicine at Mount Sinai
OHSU Knight Cancer Institute
Brigham and Women's Hospital
Associació per a la Recerca Oncologica, Spain
Emory University
Hoosier Cancer Research Network
Stanford University
City of Hope Medical Center
University of Washington
Masonic Cancer Center, University of Minnesota
University Health Network, Toronto
University of Washington
Tianjin Medical University Second Hospital
Seattle Institute for Biomedical and Clinical Research
UNICANCER
Barbara Ann Karmanos Cancer Institute
Shanghai Junshi Bioscience Co., Ltd.
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Institute of Cancer Research, United Kingdom
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cantonal Hospital of St. Gallen
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine